These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34865022)

  • 21. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transmission of SARS-CoV-2 through contact with a SARS-CoV-2-infected individual in the presymptomatic or asymptomatic state in Japan: A case series].
    Tanaka H; Ogata T; Morisada K; Tanaka S; Yoshida T; Nakanishi H; Misawa A; Nishida T; Tetsu O; Nagata M; Nakazato E
    Nihon Koshu Eisei Zasshi; 2021 Aug; 68(8):550-558. PubMed ID: 33994491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childcare Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 for 4-Year-Old Presymptomatic Child, South Korea.
    Yoon Y; Choi GJ; Kim JY; Kim KR; Park H; Chun JK; Kim YJ
    Emerg Infect Dis; 2021 Feb; 27(2):341-347. PubMed ID: 33252327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 Outbreak and Presymptomatic Transmission in Pilgrim Travelers Who Returned to Korea from Israel.
    Park JH; Jang JH; Lee K; Yoo SJ; Shin H
    J Korean Med Sci; 2020 Dec; 35(48):e424. PubMed ID: 33316860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Pediatric Age on Delta Variant Household Transmission.
    Ng OT; Koh V; Chiew CJ; Marimuthu K; Thevasagayam NM; Mak TM; Chua JK; Ong SSH; Lim YK; Ferdous Z; Johari AKB; Cui L; Lin RTP; Tan KB; Cook AR; Leo YS; Lee VJM
    Clin Infect Dis; 2022 Aug; 75(1):e35-e43. PubMed ID: 35323887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022.
    Baker JM; Nakayama JY; O'Hegarty M; McGowan A; Teran RA; Bart SM; Mosack K; Roberts N; Campos B; Paegle A; McGee J; Herrera R; English K; Barrios C; Davis A; Roloff C; Sosa LE; Brockmeyer J; Page L; Bauer A; Weiner JJ; Khubbar M; Bhattacharyya S; Kirking HL; Tate JE
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):341-346. PubMed ID: 35238860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021.
    Matsumura Y; Nagao M; Yamamoto M; Tsuchido Y; Noguchi T; Shinohara K; Yukawa S; Inoue H; Ikeda T
    Emerg Infect Dis; 2022 Aug; 28(8):1569-77. PubMed ID: 35710464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of Viral Shedding for Outbreak Surveillance of Emerging Infectious Diseases: Modeling Approach to SARS-CoV-2 Alpha and Omicron Infection.
    Lin TY; Yen AM; Chen SL; Hsu CY; Lai CC; Luh DL; Yeh YP; Chen TH
    JMIR Public Health Surveill; 2024 Sep; 10():e54861. PubMed ID: 39298261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021.
    Hagan LM; McCormick DW; Lee C; Sleweon S; Nicolae L; Dixon T; Banta R; Ogle I; Young C; Dusseau C; Salmonson S; Ogden C; Godwin E; Ballom T; Ross T; Browne H; Harcourt JL; Tamin A; Thornburg NJ; Kirking HL; Salvatore PP; Tate JE
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1349-1354. PubMed ID: 34555009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.
    Li B; Deng A; Li K; Hu Y; Li Z; Shi Y; Xiong Q; Liu Z; Guo Q; Zou L; Zhang H; Zhang M; Ouyang F; Su J; Su W; Xu J; Lin H; Sun J; Peng J; Jiang H; Zhou P; Hu T; Luo M; Zhang Y; Zheng H; Xiao J; Liu T; Tan M; Che R; Zeng H; Zheng Z; Huang Y; Yu J; Yi L; Wu J; Chen J; Zhong H; Deng X; Kang M; Pybus OG; Hall M; Lythgoe KA; Li Y; Yuan J; He J; Lu J
    Nat Commun; 2022 Jan; 13(1):460. PubMed ID: 35075154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pens down: An outbreak of the B.1.617.2 SARS-CoV-2 variant in an Australian high school, August 2021.
    Allen K; Marmor A; Pourmarzi D
    Commun Dis Intell (2018); 2022 Jul; 46():. PubMed ID: 35860870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased transmissibility of SARS-CoV-2 alpha variant (B.1.1.7) in children: three large primary school outbreaks revealed by whole genome sequencing in the Netherlands.
    Gorgels KMF; van Alphen LB; van der Veer BMJW; Hackert VH; Hensels AYJ; Heijer CDJD; Dingemans J; Savelkoul PHM; Hoebe CJPA
    BMC Infect Dis; 2022 Aug; 22(1):713. PubMed ID: 36038845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
    Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
    J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea.
    Choi G; Lim AY; Choi S; Park K; Lee SY; Kim JH
    Epidemiol Health; 2023; 45():e2023008. PubMed ID: 36596734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective control of SARS-CoV-2 transmission in Wanzhou, China.
    Shi Q; Hu Y; Peng B; Tang XJ; Wang W; Su K; Luo C; Wu B; Zhang F; Zhang Y; Anderson B; Zhong XN; Qiu JF; Yang CY; Huang AL
    Nat Med; 2021 Jan; 27(1):86-93. PubMed ID: 33257893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological Characteristics of COVID-19 Outbreak at Fitness Centers in Cheonan, Korea.
    Bae S; Kim H; Jung TY; Lim JA; Jo DH; Kang GS; Jeong SH; Choi DK; Kim HJ; Cheon YH; Chun MK; Kim M; Choi S; Chun C; Shin SH; Kim HK; Park YJ; Park O; Kwon HJ
    J Korean Med Sci; 2020 Aug; 35(31):e288. PubMed ID: 32776726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.
    Cheng HY; Jian SW; Liu DP; Ng TC; Huang WT; Lin HH;
    JAMA Intern Med; 2020 Sep; 180(9):1156-1163. PubMed ID: 32356867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2.
    Sun K; Wang W; Gao L; Wang Y; Luo K; Ren L; Zhan Z; Chen X; Zhao S; Huang Y; Sun Q; Liu Z; Litvinova M; Vespignani A; Ajelli M; Viboud C; Yu H
    Science; 2021 Jan; 371(6526):. PubMed ID: 33234698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Serial Interval of COVID-19 in Korea: 1,567 Pairs of Symptomatic Cases from Contact Tracing.
    Hong K; Yum S; Kim J; Chun BC
    J Korean Med Sci; 2020 Dec; 35(50):e435. PubMed ID: 33372427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Kim EY; Choe YJ; Park H; Jeong H; Chung JH; Yu J; Ko HP; Ahn HJ; Go MY; Lee JH; Kim WI; Lee BS; Kim S; Yu M; Kim J; Lee HR; Jang EJ; Lee JJ; Lee HY; Kim JM; Choi JH; Lee SE; Kim IH; Park AK; Rhee JE; Kim EJ; Lee S; Park YJ
    Emerg Infect Dis; 2022 Apr; 28(4):898-900. PubMed ID: 35171760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.